UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

The New England journal of medicine, 2015-01, Vol.372 (5), p.426-435

2015

Volltextzugriff (PDF)

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Haematologica (Roma), 2016-07, Vol.101 (7), p.821-829

2016

Volltextzugriff (PDF)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

British journal of haematology, 2017-01, Vol.176 (1), p.76-85

2017

Volltextzugriff (PDF)

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

European journal of haematology, 2016-08, Vol.97 (2), p.192-200

2016

Volltextzugriff (PDF)

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

British journal of haematology, 2018-07, Vol.182 (2), p.279-284

2018

Volltextzugriff (PDF)

Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia

Leukemia research reports, 2014, Vol.3 (1), p.17-20

2014

Volltextzugriff (PDF)

Efficacy and safety of epacadostat plus pembrolizumab treatment of NSCLC: Preliminary phase I/II results of ECHO-202/KEYNOTE-037

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9014-9014

2017

Volltextzugriff (PDF)

Safety of epacadostat 100 mg bid plus pembrolizumab 200 mg Q3W in advanced solid tumors: Phase 2 data from ECHO-202/KEYNOTE-037

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3012-3012

2017

Volltextzugriff (PDF)

Human reproductive biology

Jones, Mark M

2012

Volltextzugriff (PDF)

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

Journal of blood medicine, 2015-01, Vol.6 (default), p.25-29

2015

Volltextzugriff (PDF)

New Developments in Therapeutic Chelating Agents as Antidotes for Metal Poisoning

Critical reviews in toxicology, 1991, Vol.21 (3), p.209-233

Jones, Mark M.

1991

Volltextzugriff (PDF)

In vivo studies of cadmium-induced apoptosis in testicular tissue of the rat and its modulation by a chelating agent

Toxicology (Amsterdam), 1996-01, Vol.107 (1), p.1-8

1996

Volltextzugriff (PDF)

Shedding light on electrodeposition dynamics tracked in situ via soft X-ray coherent diffraction imaging

Nano research, 2016-07, Vol.9 (7), p.2046-2056

2016

Volltextzugriff (PDF)

Mobilization of Iron by Chiral and Achiral Anionic 3-Hydroxypyrid-4-ones

Journal of medicinal chemistry, 1994-12, Vol.37 (25), p.4363-4370

1994

Volltextzugriff (PDF)

Continued Treatment with Ruxolitinib Provides Additional Hematocrit Control and Spleen Volume Responses in Patients with PV Treated in the RESPONSE Study

Blood, 2015-12, Vol.126 (23), p.2804-2804

2015

Volltextzugriff (PDF)

Chelation of aluminium by combining DFO and L1 in rats

Toxicology (Amsterdam), 2000-07, Vol.147 (3), p.151-156

2000

Volltextzugriff (PDF)

The Ashgate Research Companion to John Owen's Theology

1st edition., 2012

Volltextzugriff (PDF)

Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.108-108

2018

Volltextzugriff (PDF)

Efficacy of Ruxolitinib By Baseline Spleen Volume in Patients with Polycythemia Vera Resistant to or Intolerant of Hydroxyurea

Blood, 2014-12, Vol.124 (21), p.1840-1840

2014

Volltextzugriff (PDF)

Ruxolitinib Efficacy By Hematocrit Control in Patients with Polycythemia Vera: An Analysis of the RESPONSE Trial

Blood, 2014-12, Vol.124 (21), p.3201-3201

2014

Volltextzugriff (PDF)

Chelation therapy in aluminum-loaded rats: influence of age

Toxicology (Amsterdam), 1999-10, Vol.137 (3), p.161-168

1999

Volltextzugriff (PDF)

Ruxolitinib safety experience in the polycythemia vera clinical trial program

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e18082-e18082

2015

Volltextzugriff (PDF)

A Post Hoc Landmark Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Blood, 2012-11, Vol.120 (21), p.3623-3623

2012

Volltextzugriff (PDF)

Long-Term Efficacy and Safety in COMFORT-II, a Phase 3 Study Comparing Ruxolitinib with Best Available Therapy for the Treatment of Myelofibrosis: 5-Year Final Study Results

Blood, 2015-12, Vol.126 (23), p.59-59

2015

Volltextzugriff (PDF)

1 – 25 von 8.500

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.499)
Mit Volltextzugriff
(7.185)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.010)
Life Sciences & Biomedicine
(4.751)
Humans
(3.485)
Female
(1.915)
Male
(1.889)
Biological And Medical Sciences
(1.581)
Medical Sciences
(1.202)
Adult
(1.099)
Animals
(1.086)
Middle Aged
(1.061)
Physical Sciences
(878)
Aged
(814)
Technology
(547)
Adolescent
(482)
Chemistry
(481)
Fundamental And Applied Biological Sciences. Psychology
(464)
Social Sciences
(451)
General & Internal Medicine
(434)
Risk Factors
(432)
Surgery
(396)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.458)
Free E-Journal (出版社公開部分のみ）
(3.725)
IngentaConnect
(3.420)
Journals@Ovid Ovid Full Text
(2.854)
NUS Single-Journal Subscriptions
(2.064)
Elsevier ScienceDirect Journals Complete
(1.655)
IngentaConnect Journals
(1.425)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.123)
Wiley Online Library
(1.014)
Wiley Online Library Full Collection 2018
(735)
JSTOR
(579)
Springer Journals
(502)
Oxford Journals
(415)
Nature International Weekly Journal of Science
(409)
Ebook Central Perpetual and DDA
(304)
Oxford Journals 2020 Medicine
(303)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(289)
eBooks on EBSCOhost
(273)
Nexis Uni
(273)
Taylor & Francis Journals Auto-Holdings Collection
(253)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(103)
The New England Journal Of Medicine
(92)
Nature
(86)
Journal Of Clinical Oncology
(83)
Plos One
(78)
Bioorganic & Medicinal Chemistry Letters
(75)
Nature Communications
(65)
Circulation
(64)
Proceedings Of The National Academy Of Sciences - Pnas
(59)
Cancer Research
(52)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia

Efficacy and safety of epacadostat plus pembrolizumab treatment of NSCLC: Preliminary phase I/II results of ECHO-202/KEYNOTE-037

Safety of epacadostat 100 mg bid plus pembrolizumab 200 mg Q3W in advanced solid tumors: Phase 2 data from ECHO-202/KEYNOTE-037

Human reproductive biology

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

New Developments in Therapeutic Chelating Agents as Antidotes for Metal Poisoning

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

In vivo studies of cadmium-induced apoptosis in testicular tissue of the rat and its modulation by a chelating agent

Shedding light on electrodeposition dynamics tracked in situ via soft X-ray coherent diffraction imaging

Mobilization of Iron by Chiral and Achiral Anionic 3-Hydroxypyrid-4-ones

Continued Treatment with Ruxolitinib Provides Additional Hematocrit Control and Spleen Volume Responses in Patients with PV Treated in the RESPONSE Study

Chelation of aluminium by combining DFO and L1 in rats

The Ashgate Research Companion to John Owen's Theology

Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study

Efficacy of Ruxolitinib By Baseline Spleen Volume in Patients with Polycythemia Vera Resistant to or Intolerant of Hydroxyurea

Ruxolitinib Efficacy By Hematocrit Control in Patients with Polycythemia Vera: An Analysis of the RESPONSE Trial

Chelation therapy in aluminum-loaded rats: influence of age

Ruxolitinib safety experience in the polycythemia vera clinical trial program

A Post Hoc Landmark Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Long-Term Efficacy and Safety in COMFORT-II, a Phase 3 Study Comparing Ruxolitinib with Best Available Therapy for the Treatment of Myelofibrosis: 5-Year Final Study Results

Suchergebnisse filtern